Analyst Ratings for Moderna (MRNA) [Neutrals]
MRNA Rating Summary
MRNA Price Target Summary
- Highest: $506.00 (Brookline Capital Markets)
- Lowest: $131.00 (JPMorgan)
- Average: $237.57
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$237.57 (+71.6%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 33%
Rating Score: 3.8 / 10

Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
2/1/2022 | Redburn | Simon Baker | Upgrade | Neutral (Sell) |
N/A (N/A) |
159.47 (138.46) |
-13.17% | Details |
1/26/2022 | Deutsche Bank » Updated 3/7/2022 |
Emmanuel Papadakis | Upgrade | Hold (Sell) |
155.00 (175.00) |
157.30 (138.46) |
-11.98% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |